asteatosis asteatosis eczema
Conditions
Interventions
Measurement of blood volume and microvascular structure by RSOM
Sponsors
Kawasaki Medical School
Hiroshima University Research Institute for Nanodevice
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with asteatosis or asteatosis eczema who have skin symptom at the lower legs and are 30 years or older
Exclusion criteria
Exclusion criteria: Patients who have used any topical preparation (including over-the-counter drugs, quasi-drugs, or cosmetics) on their lower leg within 7 days preceding the visit Patients who are using medication for diabetes treatment or are on dialysis Patients who are using anticancer drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference of basal sweating on lower legs in healthy subjects and patients (before treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| The difference of microvascular structure, blood volume , the water content of the stratum corneum, sebum and overall dry skin score of the lower legs in healthy subjects and patients (before treatment). Changes over time of basal sweating, blood volume, microvascular structure, the water content of the stratum corneum, sebum, overall dry skin score and pruritus NRS of the lower legs in patients after treatment. Changes over time in basal sweating, blood volume, microvascular structure, sebum, the water content of the stratum corneum, overall dry skin score and pruritus NRS of the lower legs after treatment by difference of topical application in patients. Cluster classification based on 3 axes: number of sweating drops on the ridge, number of sweating drops in the fold, and skin microstructure. | — |
Countries
Japan
Contacts
Public ContactYUMI AOYAMA
Kawasaki Medical School Department of Dermatology
Outcome results
None listed